+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030 - Product Thumbnail Image

Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030

  • Report
  • April 2019
  • 850 Pages
  • Global
From
The State of the Biopharmaceutical Industry 2025 (Mid-Year) Edition - Product Thumbnail Image

The State of the Biopharmaceutical Industry 2025 (Mid-Year) Edition

  • Report
  • June 2025
  • 127 Pages
  • Global
From
Trigeminal Neuralgia- Pipeline Insight, 2025 - Product Thumbnail Image

Trigeminal Neuralgia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Orphan Drugs Market Report 2025 - Product Thumbnail Image

Orphan Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Viral Vectors and Plasmid DNA Manufacturing Market (2nd Edition), 2018-2030 - Product Thumbnail Image

Viral Vectors and Plasmid DNA Manufacturing Market (2nd Edition), 2018-2030

  • Report
  • April 2018
  • 449 Pages
  • Global
From
Cell and Gene Therapy Market 2022-2026 - Product Thumbnail Image

Cell and Gene Therapy Market 2022-2026

  • Report
  • September 2022
  • 120 Pages
  • Global
From
New Drug Approvals and Their Contract Manufacture - 2024 Edition - Product Thumbnail Image

New Drug Approvals and Their Contract Manufacture - 2024 Edition

  • Report
  • April 2024
  • 87 Pages
  • Global
From
LAMEA Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Country and Growth Forecast, 2023 - 2030

  • Report
  • January 2024
  • 183 Pages
  • Africa, Middle East
From
North America Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Country and Growth Forecast, 2023 - 2030

  • Report
  • January 2024
  • 163 Pages
  • North America
From
Europe Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Country and Growth Forecast, 2023 - 2030

  • Report
  • January 2024
  • 187 Pages
  • Europe
From
Asia Pacific Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Country and Growth Forecast, 2023 - 2030

  • Report
  • January 2024
  • 189 Pages
  • Asia Pacific
From
Ischemic Stroke Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Ischemic Stroke Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • January 2024
  • 110 Pages
  • Global
From
Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 118 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Market Report and Forecast 2025-2034 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Sicca Syndrome Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Sicca Syndrome Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • September 2024
  • 110 Pages
  • Global
From
Pharmerging Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Pharmerging Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 102 Pages
  • Global
From
Rhematoid Arthritis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Rhematoid Arthritis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • August 2024
  • 93 Pages
  • Global
From
Nuclear Receptor ROR-Gamma Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Nuclear Receptor ROR-Gamma Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2024
  • 99 Pages
  • Global
From
Cutaneous Lupus Erythematosus Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Cutaneous Lupus Erythematosus Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • September 2023
  • 111 Pages
  • Global
From
Loading Indicator